These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate. Young CA; Williams IR; MacFarlane IA Br J Clin Pract; 1991; 45(1):61-2. PubMed ID: 1931550 [TBL] [Abstract][Full Text] [Related]
6. Adrenal insufficiency secondary to inappropriate oral administration of topical exogenous steroids presenting with hypercalcaemia. Bhatti RS; Flynn MD BMJ Case Rep; 2012 Jun; 2012():. PubMed ID: 22729340 [TBL] [Abstract][Full Text] [Related]
7. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression. Eriksen K Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159 [TBL] [Abstract][Full Text] [Related]
8. Cushing's syndrome and adrenocortical insufficiency caused by topical steroids: misuse or abuse? Güven A; Gülümser O; Ozgen T J Pediatr Endocrinol Metab; 2007 Nov; 20(11):1173-82. PubMed ID: 18183788 [TBL] [Abstract][Full Text] [Related]
9. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)]. van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134 [No Abstract] [Full Text] [Related]
10. Cushing's syndrome caused by topical steroid therapy for psoriasis. Abma EM; Blanken R; De Heide LJ Neth J Med; 2002 Apr; 60(3):148-50. PubMed ID: 12164372 [TBL] [Abstract][Full Text] [Related]
11. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents. Kimball AB; Gold MH; Zib B; Davis MW; J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358 [TBL] [Abstract][Full Text] [Related]
12. Topical corticosteroids and secondary adrenal insufficiency: a relationship in the shade. Márquez Pardo R; Pérez Pelayo M; Aragoneses Calvo A; Gallego Rodriguez S; Martínez Barbeito MB Endocrinol Nutr; 2013 Nov; 60(9):e19-20. PubMed ID: 24076040 [No Abstract] [Full Text] [Related]
13. Topical clobetasol-17-propionate: review of its clinical efficacy and safety. Olsen EA; Cornell RC J Am Acad Dermatol; 1986 Aug; 15(2 Pt 1):246-55. PubMed ID: 3528243 [TBL] [Abstract][Full Text] [Related]
14. Efficacy and safety of twice-daily augmented betamethasone dipropionate lotion versus clobetasol propionate solution in patients with moderate-to-severe scalp psoriasis. Katz HI; Lindholm JS; Weiss JS; Shavin JS; Morman M; Bressinck R; Cornell R; Pariser DM; Pariser RJ; Weng W Clin Ther; 1995; 17(3):390-401. PubMed ID: 7585843 [TBL] [Abstract][Full Text] [Related]